<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        116-368-09
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2009
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        VOLTIC -D 50MG DISPERSIBLE TABLETS
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        DICLOFENAC SODIUM
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        50
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        mg
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Oral use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Dispersible tablet
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        20
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Blister
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        36
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        do not store above 30°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        26.60
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="Jamjoom Pharmaceuticals Factory Company" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            Jamjoom Pharmaceuticals Factory Company
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 394]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            JAMJOOM PHARMACEUTICALS CO. LTD.
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            Jamjoom Pharmaceuticals Factory  Company
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        M01AB05
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Diclofenac , the active ingredient in Voltic-D&trade; dispersible tablets, is one of a group of<br />medicines called non-steroidal anti-inflammatory drugs (NSAIDs). NSAIDs reduce<br />pain and inflammation.<br />Voltic-D&trade; dispersible tablets act quickly and so are used to treat short term painful<br />conditions affecting the joints and muscles. They are especially useful for the treatment<br />of sprains, strains and back pain. They should not be taken for more than three months</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Some people MUST NOT take Voltic-D&trade; dispersible tablets. Talk to your doctor if:<br />&bull; you think you may be allergic to diclofenac sodium, aspirin, ibuprofen or any other<br />NSAID, or to any of the other ingredients of Voltic-D&trade; dispersible tablets. (These are<br />listed in section 6.) Signs of a hypersensitivity reaction include swelling of the face and<br />mouth (angioedema), breathing problems, runny nose, skin rash or any other allergic<br />type reaction.<br />&bull; you have now, or have ever had, a stomach (gastric) or duodenal (peptic) ulcer, or<br />bleeding in the digestive tract (this can include blood in vomit, bleeding when<br />emptying bowels, fresh blood in faeces or black, tarry faeces).<br />&bull; you have had stomach or bowel problems after you have taken other NSAIDs.<br />&bull; you have severe heart, kidney or liver failure.<br />&bull; if you have established heart disease and/or cerebrovascular disease e.g. if you have<br />had a heart attack, stroke, mini-stroke TIA) or blockages to blood vessels to the heart or<br />brain or an operation to clear bypass blockages.<br />&bull; if you have or have had problems with your blood circulation (peripheral arterial<br />disease)<br />&bull; you are more than six months pregnant.<br />You should also ask yourself these questions before taking Voltic-D&trade; dispersible<br />tablets:<br />&bull; Do you suffer from any stomach or bowel disorders including ulcerative colitis or<br />Crohn&#39;s disease?<br />&bull; Do you have kidney or liver problems, or are you elderly?<br />&bull; Do you have a condition called porphyria?<br />&bull; Do you suffer from any blood or bleeding disorder? If you do, your doctor may ask<br />you to go for regular check-ups while you are taking these tablets.<br />&bull; Have you ever had asthma?<br />&bull; Are you breast-feeding?<br />&bull; Do you have angina, blood clots, high blood pressure, raised cholesterol or raised<br />triglycerides?<br />&bull; Do you have heart problems, or have you had a stroke, or do you think you might be<br />at risk of these conditions (for example, if you have high blood pressure, diabetes, or<br />high cholesterol or are you a smoker)?<br />&bull; Do you have diabetes?<br />&bull; Do you have Lupus (SLE) or any similar condition?<br />If the answer to any of these questions is YES, discuss your treatment with your<br />doctor or pharmacist because Voltic-D&trade; dispersible tablets might not be the right<br />medicine for you.<br />Are you taking other medicines?<br />Some medicines can interfere with your treatment. Tell your doctor or pharmacist if<br />you are taking any of the following:<br />&bull; Medicines to treat diabetes.<br />&bull; Anticoagulants (blood thinning tablets like warfarin).<br />&bull; Diuretics (water tablets).<br />&bull; Lithium (used to treat some mental problems).<br />&bull; Methotrexate (for some inflammatory diseases and some cancers).<br />&bull; Ciclosporin and tacrolimus (used to treat some inflammatory diseases and after<br />transplants).<br />&bull; Trimethoprim (a medicine used to prevent or treat urinary tract infections).<br />&bull; Quinolone antibiotics (for infections).<br />&bull; Any other NSAID or COX-2 (cyclo-oxgenase-2) inhibitor, for example aspirin or<br />ibuprofen.<br />&bull; Mifepristone (a medicine used to terminate pregnancy).<br />&bull; Cardiac glycosides (for example digoxin), used to treat heart problems.<br />&bull; Medicines known as SSRIs used to treat depression.<br />&bull; Oral steroids (an anti-inflammatory drug).<br />&bull; Medicines used to treat heart conditions or high blood pressure, for example betablockers<br />or ACE inhibitors.<br />&bull; Voriconazole (a medicine used to treat fungal infections).<br />&bull; Phenytoin (a medicine used to treat seizures).<br />&bull; Colestipol/cholestyramine (used to lower cholesterol).<br />Always tell your doctor or pharmacist about all the medicines you are taking. This<br />means medicines you have bought yourself as well as medicines on prescription from<br />your doctor.<br />&bull; Pregnancy<br />Are you pregnant or planning to become pregnant? Although not common,<br />abnormalities have been reported in babies whose mothers have taken NSAIDs during<br />pregnancy. You should not take Voltic-D&trade; dispersible tablets during the last 3 months<br />of pregnancy as it may affect the baby&rsquo;s circulation.<br />&bull; Are you trying for a baby? Taking Voltic-D&trade; dispersible tablets may make it more<br />difficult to conceive. You should talk to your doctor if you are planning to become<br />pregnant, or if you have problems getting pregnant.<br />Driving and using machines<br />Very occasionally people have reported that Voltic-D&trade; dispersible tablets have made<br />them feel dizzy, tired or sleepy. Problems with eyesight have also been reported. If you<br />are affected in this way, you should not drive or operate machinery.<br />Other special warnings<br />&bull; You should take the lowest dose of Voltic-D&trade; dispersible tablets for the shortest<br />possible time, particularly if you are underweight or elderly.<br />&bull; There is a small increased risk of heart attack or stroke when you are taking any<br />medicine like Voltic-D&trade;. The risk is higher if you are taking high doses for a long time.<br />Always follow the doctor&rsquo;s instructions on how much to take and how long to take it<br />for.<br />&bull; Whilst you are taking these medicines your doctor may want to give you a check-up<br />from time to time.<br />&bull; If you have a history of stomach problems when you are taking NSAIDs, particularly<br />if you are elderly, you must tell your doctor straight away if you notice any unusual<br />symptoms.<br />&bull; Because it is an anti-inflammatory medicine, Voltic-D&trade; dispersible tablets may reduce<br />the symptoms of infection, for example headache, and high temperature. If you feel<br />unwell and need to see a doctor, remember to tell him or her that you are taking<br />Voltic-D&trade; dispersible tablets.<br />&bull; Voltic-D&trade; dispersible tablets are not suitable for children.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>The doctor will tell you how many Voltic-D&trade; dispersible tablets to take and when to<br />take them. Always follow his/her instructions carefully. The dose will be on the<br />pharmacist&rsquo;s label. Check the label carefully. If you are not sure, ask your doctor or<br />pharmacist. Keep taking your tablets for as long as you have been told, unless you have<br />any problems. In that case, check with your doctor.<br />Take the tablets before or with food.<br />Drop the tablets into a glass of water, and stir. Drink the liquid at once. To make sure<br />you get all of the medicine, rinse the glass round with a small amount of water and<br />drink this as well.<br />The usual doses are:<br />Adults<br />One tablet two or three times a day.<br />Elderly<br />Your doctor may advise you to take a dose that is lower than the usual adult dose if you<br />are elderly. Your doctor may also want to check closely that the Voltic-D&trade; dispersible<br />tablets are not affecting your stomach.<br />These tablets are not suitable for children.<br />The doctor may also prescribe another drug to protect the stomach to be taken at the<br />same time, particularly if you have had stomach problems before, or if you are elderly,<br />or taking certain other drugs as well.<br />What if you forget to take a dose?<br />If you forget to take a dose, take one as soon as you remember. If it is nearly time for<br />your next dose, though, just take the next dose and forget about the one you missed. Do<br />not double up on the next dose to make up for the one missed. Do not take more than<br />150 mg (three tablets) in 24 hours.</p><p>What if you take too many tablets?<br />If you, or anyone else, accidentally takes too much, tell your doctor or your nearest<br />hospital casualty department. Take your medicine pack with you so that people can<br />see what you have taken</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Voltic-D&trade; dispersible tablets are suitable for most people, but, like all medicines, they<br />can sometimes cause side effects. Side effects may be minimised by using the lowest<br />effective dose for the shortest duration necessary.<br />Some side effects can be serious<br />Stop taking Voltic-D&trade; dispersible tablets and tell your doctor straight away if<br />you notice:<br />&bull; Stomach pain, indigestion, heartburn, wind, nausea (feeling sick) or vomiting (being<br />sick).<br />&bull; Any sign of bleeding in the stomach or intestine, for example, when emptying your<br />bowels, blood in vomit or black, tarry faeces.<br />&bull; Allergic reactions which can include skin rash, itching, bruising, painful red areas,<br />peeling or blistering.<br />&bull; Wheezing or shortness of breath (bronchospasm).<br />&bull; Swollen face, lips, hands or fingers.<br />&bull; Yellowing of your skin or the whites of your eyes.<br />&bull; Persistent sore throat or high temperature.<br />&bull; An unexpected change in the amount of urine produced and/or its appearance.<br />If you notice that you are bruising more easily than usual or have frequent sore<br />throats or infections, tell your doctor.<br />The side effects listed below have also been reported.<br />Common side effects (These may affect between 1 and 10 in every 100 patients):<br />&bull; Stomach pain, heartburn, nausea, vomiting, diarrhoea, indigestion, wind, loss of<br />appetite.<br />&bull; Headache, dizziness, vertigo.<br />&bull; Skin rash or spots.<br />&bull; Raised levels of liver enzymes in the blood.<br />Rare side effects (These may affect between 1 in every 1000 to 1 in every 10,000<br />patients):<br />&bull; Stomach ulcers or bleeding (there have been very rare reported cases resulting in<br />death, particularly in the elderly).<br />&bull; Gastritis (inflammation, irritation or swelling of the stomach lining).<br />&bull; Vomiting blood.<br />&bull; Diarrhoea with blood in it or bleeding from the back passage.<br />&bull; Black, tarry faeces or stools.<br />&bull; Drowsiness, tiredness.<br />&bull; Hypotension (low blood pressure, symptoms of which may include faintness,<br />giddiness or light headedness).<br />&bull; Skin rash and itching.<br />&bull; Fluid retention, symptoms of which include swollen ankles.<br />&bull; Liver function disorders, including hepatitis and jaundice.<br />Very Rare side effects (These may affect less than 1 in every 10,000 patients):<br />Effects on the nervous system:<br />Tingling or numbness in the fingers, tremor, visual disturbances such as blurred or<br />double vision, hearing loss or impairment, tinnitus (ringing in the ears), sleeplessness,<br />nightmares, mood changes, depression, anxiety, mental disorders, disorientation and<br />loss of memory, fits, headaches together with a dislike of bright lights, fever and a<br />stiff neck, disturbances in sensation.<br />Effects on the stomach and digestive system:<br />Constipation, inflammation of the tongue, mouth ulcers, inflammation of the inside of<br />the mouth or lips, taste changes, lower gut disorders (including inflammation of the<br />colon, or worsening of ulcerative colitis or Crohn&rsquo;s disease).<br />Effects on the heart, chest or blood:<br />Palpitations (fast or irregular heart beat), chest pain, hypertension (high blood<br />pressure), inflammation of blood vessels (vasculitis), inflammation of the lung<br />(pneumonitis), heart disorders, including congestive heart failure or heart attack,<br />blood disorders (including anaemia), stroke.<br />Effects on the liver or kidneys:<br />Kidney or severe liver disorders including liver failure, presence of blood or protein<br />in the urine.<br />Effects on skin or hair:<br />Serious skin rashes including Stevens-Johnson syndrome and Lyell&rsquo;s syndrome and<br />other skin rashes which may be made worse by exposure to sunlight.<br />Hair loss.<br />Other side effects that have also been reported include:<br />Inflammation of the pancreas, impotence. Facial swelling, inflammation of the lining<br />of the brain (meningitis), stroke, throat disorders, confusion, hallucinations, malaise<br />(general feeling of discomfort), inflammation of the nerves in the eye.<br />Do not be alarmed by this list - most people take Voltic-D&trade; dispersible tablets<br />without any problems.<br />If any of the symptoms become troublesome, or if you notice anything else not<br />mentioned here, please go and see your doctor. He/she may want to give you a<br />different medicine.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>&bull; Keep out of the reach and sight of children.<br />&bull; Do not store above 30 &ordm;C, Protect from moisture<br />&bull; Keep the tablets in their original pack.<br />&bull; Do not take Voltic-D&trade; dispersible tablets after the expiry date which is printed on<br />the outside of the pack.<br />&bull; Medicines should not be disposed of via waste water or household waste. Ask your<br />pharmacist how to dispose of medicines no longer required. This will help protect the<br />environment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>The active substances is diclofenac . Each tablet contains 46.5mg of diclofenac ,<br />which is equivalent to 50mg of diclofenac sodium.<br />The other ingredients are colloidal silicon dioxide, crospovidone, microcrystalline<br />cellulose PH 102, povidone and sodium lauryl sulphate.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                Voltic-D™ dispersible tablets are white to off white round, biconvex uncoated tablets,
engraved with 'JP101' on one side and plain on the other side.
Voltic-D™ 50mg available in a box of 20 dispersible tablets .
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Jamjoom Pharmaceuticals Co., Ltd., Jeddah, Saudi Arabia.<br />Tel: +966-12-6081111, Fax: +966-12-6081222.<br />Website: www.jamjoompharma.com<br />To report any side effect(s):<br />&bull; Saudi Arabia:<br />The National Pharmacovigilance and Drug Safety Centre (NPC)<br />Fax: +966-11-205-7662<br />Call NPC at +966-11-2038222, Exts: 2317-2356-2353-2354-2334-2340.<br />Toll free phone: 8002490000<br />E-mail: npc.drug@sfda.gov.sa<br />Website: www.sfda.gov.sa/npc<br />&bull; Other GCC States:<br />&minus; Please contact the relevant competent authority.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                04/2014
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p>&nbsp;إن الديكلوفيناك ، المادة الفعالة في أقراص فولتك-د&nbsp;القابلة للإنتشار، هي واحدة من مجموعة من<br />ذات الخاصية المسكنة للألم والمضادة (NSAIDs) الأدوية تسمى مضادات الالتهاب غير الستيرويدية<br />للالتهابات.<br />&nbsp; تعطي أقراص فولتك-د&nbsp;القابلة للإنتشار مفعولاً سريعاً ولهذا يتم استخدامها لعلاج حالات الألم قصير<br />المدى التي تؤثر على المفاصل والعضلات. وهي مفيدة خاصة في علاج حالات الالتواء، وإجهاد وآلام&nbsp;الظهر .<br />لا ينبغي أن تؤخذ أقراص فولتك-د القابلة للإنتشار لأكثر من ثلاثة أشهر.&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>&nbsp;۲. قبل أن تبدأ في تناول أقراص فولتك-دالقابلة للإنتشار،</p><p>يجب أن يمتنع بعض الأشخاص عن تناول أقراص فولتك-د&nbsp;تحدث إلى طبيبك إذا:<br />&bull; كنت تعتقد انك تعاني من حساسية تجاه ديكلوفيناك الصوديوم، الأسبرين ، الإبيوبروفين أو أي من<br />مضادات الالتهاب غير الستيرويدية الأخرى أو لأي من المكونات الأخرى لأقراص فولتك-د&nbsp;القابلة<br />للإنتشار (وهي مذكورة في القسم رقم ٦). تشمل أعراض التفاعلات التحسسية المفرطة، تورم في<br />الوجه و الفم و مشاكل في التنفس و رشح في الأنف و طفح بالجلد أو أي علامات أخرى للحساسية.<br />&bull; كنت تعاني حالياً أو سابقاً قرحة بالمعدة أو بالاثنى عشر أو نزيف في القناة الهضمية ( وجود قيء<br />دموي أو وجود دم أثناء التبرز أو دم حديث في البراز أو وجود براز أسود أو قطراني).<br />&bull; كان لديك مشاكل في المعدة أو الأمعاء بعد تناول أنواع أخرى من مضادات الالتهاب غير<br />الستيرويدية.<br />&bull; كان لديك قصور حاد في الكلى أو الكبد أو القلب.<br />&bull; كان لديك أمراض القلب و / أو الأمراض القلبية الوعائية على سبيل المثال إذا كان لديك سابقا أزمة<br />أو انسداد الأوعية الدموية إلى القلب أو الدماغ أو (TIA) قلبية، سكتة دماغية وسكتة دماغية مصغرة<br />عملية لتجاوز انسداد.<br />&bull; إذا كان لديك حاليا أوسابقا مشاكل مع الدورة الدموية (أمراض الشرايين الطرفية).<br />&bull; كنتِ سيدة حامل لأكثر من ستة أشهر.<br />القابلة للإنتشار: &trade; يجب أن تسأل نفسك أيضاً بعض الأسئلة قبل تناول أقراص فولتك-د<br />&bull; هل تعاني من أي اضطرابات في المعدة أو الأمعاء وتشمل التهاب القولون التقرحي أو داء كرون؟<br />&bull; هل تعاني من مشاكل في الكلى أو الكبد أو هل أنت من كبار السن؟<br />&bull; هل تعاني من حالة تسمّى البُرْفيرِيَّة؟<br />&bull; هل تعاني من أي اضطرابات في الدم أو النزيف؟ و إذا كنت كذلك فربما يطلب منك طبيبك الذهاب<br />لعمل فحص دوري أثناء تناولك تلك الأقراص.<br />&bull; هل عانيت من نوبات الربو أي وقت مضى؟<br />&bull; هل تقومين بالرضاعة الطبيعية؟<br />&bull; هل لديك ذبحة صدرية، جلطات الدم، ارتفاع ضغط الدم، ارتفاع الكوليسترول أو الدهون الثلاثية؟<br />&bull; هل لديك مشاكل بالقلب أو هل أُصبت بسكتة دماغية؟ أو هل تعتقد أنك معرض لخطر الإصابة بهذه<br />الأمراض (مثلاً تعاني من ضغط الدم المرتفع أو داء السكري أو ارتفاع نسبة الكوليستيرول في الدم أو<br />كونك شخص مدخِن)؟<br />&bull; هل لديك مرض السكري؟<br />&bull; هل تعاني من مرض الذئبة الحمراء (الذئبة الحُمَامِيَّة) أو أي حالات مشابهة لذلك؟<br />إذا كانت الإجابة بنعم على أي من هذه الأسئلة، ناقش العلاج الخاص بك مع طبيبك أو الصيدلي لأنه<br />من المحتمل أن تكون أقراص فولتك-دالقابلة للإنتشار دواء غير مناسب لك.&nbsp;<br />هل تتناول أدوية أخرى؟<br />تتداخل بعض الأدوية مع العلاج الذي تتناوله. أخبر طبيبك أو الصيدلي إذا كانت تتعاطى اي من<br />الأدوية الآتية:<br />- أدوية علاج السكر.<br />- مضادات التجلط (مثل الوارفارين).<br />- مدرات البول.<br />- الليثيوم (يستخدم لعلاج بعض الاضطرابات العقلية).<br />- الميثوتريكسات (يستخدم لعلاج بعض الالتهابات و بعض أنواع السرطان).<br />- السيكلوسبورين و التاكروليمس (يستخدمان لعلاج بعض الالتهابات و بعد زراعة الاعضاء).<br />- ترايميثوبريم (دواء يستخدم للوقاية أو لعلاج عدوى المسالك البولية).<br />- الكينولون (من المضادات الحيوية لعلاج العدوى البكتيرية).<br />- أي أنواع أخرى من من مضادات الالتهاب غير الستيرويدية أو مثبطات انزيم السيكلواوكسي چينيز ۲<br />مثل الأسبيرين أو الابيوبروفين.<br />- ميفيبريستون (دواء يستخدم لإنهاء الحمل &quot;الإجهاض&quot;).<br />- الجليكوزيدات القلبية (مثل الديجوكسين) لعلاج مشاكل القلب.<br />و التي تستخدم لعلاج الاكتئاب. SSRIs - مثبطات استرجاع السيروتونين الإنتقائية<br />- الستيرويدات التي تؤخذ عن طريق الفم (وهي مواد مضادة للالتهاب).<br />- الأدوية التي تستخدم لعلاج الحالات القلبية أو ارتفاع ضغط الدم مثل حاصرات البيتا و مثبطات<br />الانزيم المحول للأنجيوتنسين.<br />- ڤوريكونازول (دواء يستخدم لعلاج العدوى الفطرية).<br />- الفينيتوين (دواء يستخدم لعلاج نوبات التشنجات).<br />- الكوليستيبول / الكوليستيرامين (يستخدمان لخفض نسبة الكوليستيرول في الدم).<br />أخبر طبيبك دائماً عن كل الأدوية التي تتناولها. وهذا يعني الأدوية التي قمت بشرائها من تلقاء نفسك أو<br />تلك التي وصفها لك الطبيب.<br />الحمل:<br />- هل أنتِ حامل أو تتوقعي أن تصبحين حامل؟ لوحظ ظهور بعض التشوهات في مواليد الأمهات<br />اللاتي تناولن مضادات الالتهاب غير الستيرويدية أثناء فترة الحمل بالرغم من كون ذلك غير شائع.<br />القابلة للإنتشار في الشهور الثلاث الأخيرة من الحمل &trade; يجب عليكِ الامتناع عن تناول أقراص فولتك-د<br />و ذلك لاحتمال تأثيره على الدورة الدموية للطفل.<br />&nbsp;- هل تحاولين أن تصبحي حامل؟ تناول أقراص فولتك-د&nbsp;القابلة للإنتشار يمكن أن يسبب صعوبة في<br />حدوث الحمل. يجب عليك التحدث مع طبيبك إذا كنتِ تخططين لتصبحي حاملاً أو إذا كنتِ تواجهين<br />صعوبة في حدوث الحمل.<br />قيادة المركبات و استخدام الآلات<br />في قليل من الأحيان سجل بعض الأشخاص اصابتهم بدوار أو ارهاق أو نعاس بعد تناولهم أقراص&nbsp;فولتك-د<br />القابلة للإنتشار. لوحظ أيضاً حدوث بعض الاضطرابات في الرؤية، إذا لاحظت ظهور مثل&nbsp;<br />تلك الأعراض فعليك بتجنب القيادة أو تشغيل المعدات.<br />احتياطات اخرى خاصة:<br />يجب عليك تناول الجرعة الأقل من أقراص فولتك-د القابلة للإنتشار لأقصر مدّة ممكنة خاصةً إذا&nbsp; -<br />كنت منخفض الوزن أو من كبار السن.<br />- يوجد احتمال بسيط لزيادة مخاطر الإصابة بالنوبات القلبية أو السكتات الدماغية عندما تتناول أية&nbsp; أدوية مثل أقراص فولتك-د<br />القابلة للإنتشار. وتزيد الخطورة عندما تقوم بتناوله بجرعات كبيرة و لمدة&nbsp;<br />طويلة. اتبع دائماً ارشادات طبيبك حول الجرعة و المدة المناسبة لتناول الدواء.<br />- في أثناء تناولك هذه الأدوية، يمكن أن يقوم طبيبك بعمل فحص لك من وقت لآخر.<br />- إذا كان لديك تاريخ مرضي من اضطرابات المعدة عند تناول مضادات الالتهاب غير الستيرويدية،<br />خاصة إذا كنت من كبار السن، يجب عليك ابلاغ طبيبك مباشرة فور ملاحظتك حدوث أي أعراض غير<br />عادية.<br />تستطيع أقراص فولتك-د القابلة للإنتشار أن تخفف من أعراض العدوى مثل الصداع و ارتفاع&nbsp;<br />درجة الحرارة لأنها مستحضر مضاد للإلتهاب. إذا شعرت بأنك لست على ما يرام و تحتاج إلى زيارة<br />الطبيب تذكر أن تبلغه بأنك تتناول أقراص فولتك-د&nbsp;القابلة للإنتشار<br />لا تناسب أقراص فولتك-د القابلة للإنتشار الأطفال.<br />&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>سوف يخبرك الطبيب بعدد و مواعيد جرعات فولتك-دالقابلة للإنتشار التي يجب أن تتناولها.</p><p>إتبع دائماً ارشادات الطبيب بعناية. سوف تدون الجرعة على الملصق الذي يضعه الصيدلي على العبوة،<br />إقرأها بعناية و إذا كنت غير متأكداً إسأل طبيبك أو الصيدلي. أكمل عدد الجرعات الموصوفة لك إلا إذا<br />شعرت باي مشاكل عندئذٍ قم باستشارة طبيبك. قم بتناول الأقراص قبل أو أثناء الطعام، ضع القرص في<br />كوب من الماء، وقم بتقليبه. اشرب السائل دفعة واحدة. للتأكد من أنك تناولت كل كمية الدواء الموجودة،<br />قم بشطف الكوب بكمية صغيرة من الماء واشربه بالإضافة الى الكمية السابقة.<br />الجرعة المعتادة هي:<br />البالغين:<br />قرص واحد مرتين أو ثلاث مرات في اليوم.<br />- كبار السن<br />يمكن أن يصف لك الطبيب جرعة أقل من المعتاد بالنسبة للبالغين إذا كنت من كبار السن. يمكن أن<br />يحتاج طبيبك أيضاً إلى فحص معدتك للتأكد من أن فولتك-د القابلة للإنتشار لا تؤثر عليها.&nbsp;<br />لا تناسب أقراص فولتك-د القابلة للإنتشار الأطفال.&nbsp;<br />يمكن أن يصف الطبيب دواء آخر يؤخذ في نفس الوقت لحماية المعدة خاصة إذا كنت تعاني سابقاً من<br />مشاكل بالمعدة أو كنت من كبار السن أو تقوم بتناول أدوية أخرى في نفس الوقت.<br />ماذا إذا نسيت تناول إحدى الجرعات؟<br />إذا نسيت تناول إحدى الجرعات قم بأخذها بمجرد أن تتذكر. إذا كان وقت جرعتك التالية قد حان فقم<br />بتناولها وانسى الأمر بالنسبة للجرعة السابقة ولا تقم بمضاعفة الجرعة لتعويض تلك التي نسيتها. لا<br />تتناول أكثر من 150 ملجم ( ثلاثة أقراص) خلال 24 ساعة.</p><p>&nbsp;ماذا إذا قمت بتناول أقراص فولتك-د&nbsp;لقابلة للإنتشار بكمية أكثر من المطلوب؟<br />إذا تناولت انت أو غيرك بطريق الخطأ أقراص فولتك-د القابلة للإنتشار بكمية أكثر من المطلوب&nbsp;&nbsp;<br />أخطر طبيبك أو قسم الحوادث في أقرب مستشفى لك. أثناء ذلك قم بأخذ علبة الدواء معك حتى يتعرف<br />المسعفين على نوع الدواء الذي تناولته.<br />&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p>يمكن أن تتناسب أقراص فولتك-د القابلة للإنتشار مع معظم الأشخاص و لكنها مثل أي دواء آخر<br />تتسبب في حدوث آثار جانبية. يمكن التقليل من الآثار الجانبية باستخدام أقل جرعة فعالة لأقصر مدة<br />لازمة.<br />يمكن أن تكون بعض الآثار الجانبية خطيرة، توقف عن تناول أقراص فولتك-د القابلة للإنتشار&nbsp;&nbsp;<br />وأخبر طبيبك على الفور إذا لاحظت الآتي:<br />- ألم بالمعدة، عسر في الهضم، حرقة في المعدة، غازات، غثيان، أو قئ.<br />- أي علامات للنزيف من المعدة أو الأمعاء مثال على ذلك ملاحظة وجود دم عند الإخراج أو عند التقيؤ<br />أو وجود براز أسود أو براز قطراني اللون.<br />- حساسية و التي تشمل طفح جلدي، حكة ، كدمات، مناطق حمراء اللون و مؤلمة، وجود تقشير أو<br />تقرحات بالجلد.<br />- أزيز أو صعوبة أثناء التنفس.<br />- تورم بالوجه أو الشفتين أو اليدين أو الأصابع.<br />- إصفرار في الجلد أو في بياض العينين.<br />- احتقان مستمر بالحلق أو ارتفاع مستمر في درجة الحرارة.<br />- حدوث تغير غير متوقع في كمية و/أو مظهر البول.<br />إذا لاحظت انك أصبحت تصاب بكدمات (مناطق زرقاء بالجلد) بشكل أكثر من المعتاد أو أنك تصاب<br />باحتقان في الحلق بشكل متكرر، أخبر طبيبك.<br />تم ذكر الآثار الجانبية المدرجة في الأسفل أيضا:<br />۱۰ من كل ۱۰۰ مريض): - الآثار الجانبية الشائعة (قد تصيب تلك الآثار ما بين ۱<br />- ألم أو حرقة بالمعدة، غثيان، قيء، اسهال، عسر في الهضم، غازات و فقدان في الشهية.<br />- صداع، دوار.<br />- طفح أو بقع في الجلد.<br />- إرتفاع نسبة إنزيمات الكبد في الدم.<br />الآثار الجانبية النادرة (يمكن أن تحدث ل ۱ من كل ۱۰۰۰ إلى ۱ من كل ۱۰۰۰۰ مريض):<br />- قرح أو نزيف بالمعدة (يوجد حالات نادرة جداً أدت إلى الوفاة خاصة في كبار السن).<br />- التهاب في المعدة (تهيج و انتفاخ في بطانة المعدة).<br />- قيء دموي.<br />- اسهال دموي أو نزيف من قناة الإخراج.<br />- براز أسود قطراني.<br />- نعاس و شعور بالإرهاق.<br />- هبوط في ضغط الدم (وأعراضه تشمل ضعف و دوار و التشوش.<br />- طفح أو حكة بالجلد.<br />- احتباس بالماء، حيث ينتفخ كاحل القدم.<br />- اعتلال في وظائف الكبد و منها التهاب الكبد الوبائي و اليرقان.<br />الآثار الجانبية النادرة جداً ( ربما تصيب أقل من ۱ كل ۱۰۰۰۰ مريض)<br />الآثار المرتبطة بالجهاز العصبي:<br />- وخز أو تنميل في الأصابع، رعشة، اضطرابات وعدم وضوح أو ازدواج في الرؤية، فقدان أو<br />ضعف في السمع، طنين بالأذن، أرق، كوابيس، تغيرات في المزاج، اكتئاب، قلق، اضطرابات نفسية،<br />ارتباك و فقدان في الذاكرة، نوبات من الغضب، صداع مع عدم تحمل الأضواء الساطعة، حمى و تيبس<br />في العنق، اضطرابات في الإحساس.<br />الآثار المرتبطة بالجهاز الهضمي والمعدة:<br />امساك، التهاب في اللسان، قرح بالفم، التهاب في داخل الفم أو الشفاه، تغير في المذاق، اضطرابات في<br />أسفل القناة الهضمية و تشمل التهابات في القولون أو تفاقم في حالة التهاب القولون التقرحي أو داء<br />كرون.<br />الآثار المرتبطة بالقلب، الصدر أو الدم:<br />خفقان (نبضات قلب سريعة أو غير منتظمة)، ألم بالصدر، ارتفاع في ضغط الدم، التهابات في الأوعية<br />الدموية، التهابات في الرئة، اضطرابات في القلب و تشمل الفشل القلبي الاحتقاني، الأزمات القلبية،<br />أمراض الدم مثل الأنيميا.<br />الآثار المرتبطة بالكلى و الكبد:<br />اضطرابات حادة في الكلى و الكبد مثل الفشل الكبدي، وجود دم أو بروتينات في البول.<br />الآثار المرتبطة بالجلد و الشعر:<br />- طفح جلدي شديد و مثال على ذلك &quot;متلازمة ستيفينز جونسون&quot; و &quot; متلازمة ليلل&quot; و غيرها مما يمكن<br />أن تزداد حالتها سوءاً عند التعرض لأشعة الشمس.<br />- تساقط الشعر.<br />آثار جانبية أخرى تم ملاحظتها:<br />التهاب في البنكرياس، ضعف القدرة الجنسية، تورم بالوجه، الإلتهاب السحائي، السكتة الدماغية،<br />اضطرابات في الحلق، ارتباك، هلوسة، الشعور بالتوعك، إلتهاب العصب البصري.<br />لا تنزعج من قراءة هذه القائمة فمعظم الأشخاص يتناولون أقراص فولتك-د القابلة للإنتشار بدون<br />حدوث أي مشاكل. إذا تفاقم أي من هذه الآثار أو لاحظت ظهور أي آثار أخرى غير مدرجة في هذه<br />القائمة فمن فضلك راجع الطبيب فربما يرغب في وصف علاج مختلف لك.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>&bull; يحفظ بعيداً عن متناول و مرأى الأطفال.<br />&bull; يحفظ في درجة حرارة لا تزيد عن ۳۰ درجة مئوية. يحفظ بعيداً عن الرطوبة.<br />&bull; أحتفظ بالأقراص في العلبة الأصلية.<br />&bull; لا تقم باستخدام أقراص فولتك-د القابلة للإنتشار بعد انتهاء تاريخ الصلاحية المطبوع على العبوة من&nbsp;<br />الخارج.<br />&bull; لا يتم التخلص من الأدوية عن طريق مياه الصرف أو النفايات المنزلية. إسأل الصيدلي عن طريقة<br />التخلص من الأدوية الغير مرغوب فيها فسوف تساعد هذه الإجراءات على حماية البيئة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>المادة الفعالة : الديكلوفيناك. يحتوي القرص الواحد على ٤٦٫٥ ملجم من الديكلوفيناك، يعادل ٥۰ ملجم<br />من ديكلوفيناك الصوديوم.<br />، PH المكونات الأخرى هي ثاني أكسيد السيليكون الغروي، كروس بوفيدون، سليلوز جريزوفولفين 102<br />البوفيدون وكبريتات لوريل الصوديوم.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p style="text-align:right">&nbsp;كيف تبدو أقراص فولتك-د٥۰ ملجم أقراص قابلة للإنتشار:<br />&trade; فولتيك- د<br />على أقراص لونها أبيض إلي مائل للأبيض ، دائرية ، محدبة الوجهين ، غير مغلفة، محفور JP101<br />جانب واحد ومستوية على الجانب الآخر.<br />فولتيك- د ٥۰ ملجم أقراص متوفرة فى عبوة تحتوي على 20 قرص قابلة للإنتشار.&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p>شركة مصنع جمجوم للأدوية المحدودة، جدة، المملكة العربية السعودية<br />- الهاتف: 608111-12-966+ فاكس :&nbsp;608222-12-966+<br />الموقع الإلكتروني:&nbsp;www.jamjoompharma.com&nbsp;<br />للإبلاغ عن أي أثار جانبيه:<br />&bull; المملكة العربية السعودية:<br />المركز الوطني للتيقظ و السلامة الدوائية<br />- فاكس: 7662-205-11-966+&nbsp;<br />للإتصال بالإدارة التنفيذية للتيقظ وإدارة الأزمات.<br />هاتف: 22228302-11-966+ تحويلة: 2317-2356-2353-2354-2334-2340<br />الهاتف المجاني: 8002490000<br />بريد إلكتروني:&nbsp;npc.drug@sfda.gov.sa<br />الموقع الالكتروني:&nbsp;www.sfda.gov.sa/npc<br />&bull; دول الخليج الأخرى:<br />الرجاء الاتصال بالمؤسسات و الهيئات الوطنية في كل دولة</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            04/2014
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Voltic-D 50 mg Dispersible Tablets.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Active substance: Diclofenac free acid. Each tablet contains 46.5mg of Diclofenac free acid,
which is equivalent to 50mg of Diclofenac sodium.
Voltic-D dispersible tablets, specifically designed to disintegrate quickly in water, yielding a
tasteless suspension of Diclofenac free acid. The suspension is to be taken orally.
For excipients, see section 6.1.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Dispersible Tablets.
White to off white round, biconvex uncoated tablets about 9.5 mm diameter engraved with
‘JP101’ on one side and plain on the other side.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Adults and Elderly:<br />The rapid onset of absorption of Diclofenac from Voltic-D Dispersible makes this preparation<br />more suitable for short-term use in acute conditions for which treatment is required for no more<br />than 3 months including: acute episodes of arthritic conditions, acute musculo-skeletal disorders<br />and acute pain resulting from trauma.<br />There is no information on the use of Diclofenac Dispersible tablets for more than 3 months.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Undesirable effects may be minimized by using the lowest effective dose for the shortest<br />duration necessary to control symptoms (see section 4.4 Special warnings and precautions for<br />use).<br />For oral administration<br />Adults<br />100-150mg daily in two or three divided doses. The Voltic-D Dispersible tablet should be<br />dropped into a glass of water, and the liquid stirred to aid dispersion, before swallowing.<br />The recommended maximum daily dose of Voltic-D is 150mg.<br />Special populations<br />Elderly<br />Although the pharmacokinetics of Diclofenac are not impaired to any clinically relevant extent in<br />elderly patients, nonsteroidal anti-inflammatory drugs should be used with particular caution in<br />such patients who generally are more prone to adverse reactions. In particular it is recommended<br />that the lowest effective dosage be used in frail elderly patients or those with a low body weight<br />(see also precautions) and the patient should be monitored for GI bleeding during NSAID<br />therapy.</p><p>Renal impairment<br />Diclofenac is contraindicated in patients with severe renal impairment (see section 4.3). No<br />specific studies have been carried out in patients with renal impairment; therefore, no specific<br />dose adjustment recommendations can be made. Caution is advised when administering<br />Diclofenac to patients with mild to moderate renal impairment (see section 4.3 and 4.4).<br />Hepatic impairment<br />Diclofenac is contraindicated in patients with severe hepatic impairment (see section 4.3). No<br />specific studies have been carried out in patients with hepatic impairment; therefore, no specific<br />dose adjustment recommendations can be made. Caution is advised when administering<br />Diclofenac to patients with mild to moderate hepatic impairment (see section 4.3 and 4.4).<br />Paediatric population<br />Not recommended.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                - Hypersensitivity to the active substance or any of the excipients.
- Active, or gastric or intestinal ulcer, bleeding or perforation.
- History of gastrointestinal bleeding or perforation, relating to previous NSAID
therapy
- Active, or history of recurrent peptic ulcer/haemorrhage (two or more distinct
episodes of proven ulceration or bleeding)
- Last trimester of pregnancy (see section 4.6 Pregnancy and lactation)
-Severe hepatic, renal or cardiac failure (see section 4.4 Special warnings and
precautions for use).
- Like other non-steroidal anti-inflammatory drugs (NSAIDs), Diclofenac is also
contraindicated in patients in whom attacks of asthma, angioedema, urticaria or acute
rhinitis are precipitated by ibuprofen, acetylsalicylic acid or other nonsteroidal antiinflammatory
drugs.
- Established congestive heart failure (NYHA II-IV), ischemic heart disease,
peripheral arterial disease and/or cerebrovascular disease.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>General<br />Undesirable effects may be minimised by using the lowest effective dose for the shortest<br />duration necessary to control symptoms (see section 4.2 Posology and Method of<br />administration and GI and cardiovascular risks below).<br />The concomitant use of Diclofenac with systemic NSAIDs including cyclooxygenase-2<br />selective inhibitors should be avoided due to the absence of any evidence demonstrating<br />synergistic benefits and the potential for additive undesirable effects (see section 4.5<br />Interactions with other medicaments and other forms of interaction).<br />Caution is indicated in the elderly on basic medical grounds. In particular, it is<br />recommended that the lowest effective dose be used in frail elderly patients or those with a<br />low body weight (see also section 4.2 Posology and Method of administration).<br />As with other NSAIDs, allergic reactions, including anaphylactic/anaphylactoid reactions,<br />can also occur in rare cases with Diclofenac without earlier exposure to the drug (see section<br />4.8 Undesirable effects).<br />Like other NSAIDs, Diclofenac may mask the signs and symptoms of the infection due to its<br />pharmacodynamic properties.<br />Gastrointestinal effects:<br />Gastrointestinal bleeding (haematemesis melaena), ulceration or perforation which can be<br />fatal has been reported with all NSAIDs including Diclofenac and may occur at any time<br />during treatment, with or without warning symptoms or a previous history of serious GI<br />events. They generally have more serious consequences in the elderly. If gastrointestinal<br />bleeding or ulceration occurs in patients receiving Voltic-D, the drug should be withdrawn.<br />As with all NSAIDs, including Diclofenac close medical surveillance is imperative and<br />particular caution should be excised when prescribing Diclofenac in patients with symptoms<br />indicative of gastrointestinal disorders, or with a history suggestive of gastric or intestinal<br />ulceration, bleeding or perforation (see section 4.8 Undesirable effects). The risk of GI<br />bleeding, ulceration or perforation is higher with increasing NSAID doses including<br />Diclofenac, and in patients with a history of ulcer, particularly if complicated with<br />haemorrhage or perforation.<br />The elderly have increased frequency of adverse reactions to NSAIDs especially gastrointestinal<br />bleeding and perforation which may be fatal (see section 4.2 Posology and Method<br />of administration).</p><p>To reduce the risk of GI toxicity in patients with a history of ulcer, particularly if<br />complicated with haemorrhage or perforation, and in the elderly, the treatment should be<br />initiated and maintained at the lowest effective dose.<br />Combination therapy with protective agents (e.g. misoprostol or proton pump inhibitors)<br />should be considered for these patients, and also for patients requiring concomitant use of<br />medicinal products containing low dose acetylsalicylic acid (ASA/aspirin or medicinal<br />products likely to increase gastrointestinal risk (see section 4.5 Interactions with other<br />medicaments and other forms of interaction).<br />Patients with a history of GI toxicity, particularly when elderly, should report any unusual<br />abdominal symptoms (especially GI bleeding).<br />Caution is recommended in patients receiving concomitant medications which could<br />increase the risk of ulceration or bleeding, such as systemic corticosteroids, anticoagulants<br />such as warfarin, selective serotonin-reuptake inhibitors (SSRIs) or anti-platelet agents such<br />as acetylsalicylic acid (see section 4.5 Interaction with other medicaments and other forms<br />of interaction).<br />Close medical surveillance and caution should be exercised in patients with ulcerative<br />colitis, or with Crohn&#39;s disease as these conditions may be exacerbated (see section 4.8<br />Undesirable effects).<br />Hepatic effects:<br />Close medical surveillance is required when prescribing Diclofenac to patients with<br />impairment of hepatic function as their condition may be exacerbated.<br />As with other NSAIDs, including Diclofenac, values of one or more liver enzymes may<br />increase. During prolonged treatment with Diclofenac, regular monitoring of hepatic<br />function is indicated as a precautionary measure.<br />If abnormal liver function tests persist or worsen, clinical signs or symptoms consistent with<br />liver disease develop or if other manifestations occur (eosinophilia, rash), Voltic-D should<br />be discontinued.<br />Hepatitis may occur with Diclofenac without prodromal symptoms.<br />Caution is called for when using Diclofenac in patients with hepatic porphyria, since it may<br />trigger an attack.</p><p>Renal effects:<br />As fluid retention and oedema have been reported in association with NSAIDs therapy,<br />including Diclofenac, particular caution is called for in patients with impaired cardiac or<br />renal function, history of hypertension, the elderly, patients receiving concomitant treatment<br />with diuretics or medicinal products that can significantly impact renal function, and those<br />patients with substantial extracellular volume depletion from any cause, e.g. before or after<br />major surgery (see section 4.3 Contraindications). Monitoring of renal function is<br />recommended as a precautionary measure when using Diclofenac in such cases.<br />Discontinuation therapy is usually followed by recovery to the pre-treatment state.<br />Skin effects:<br />Serious skin reactions, some of them fatal, including exfoliative dermatitis, Stevens-Johnson<br />syndrome and toxic epidermal necrolysis, have been reported very rarely in association with<br />the use of NSAIDs, including Voltic-D (see section 4.8 Undesirable effects). Patients appear<br />to be at the highest risk of these reactions early in the course of therapy: the onset of the<br />reaction occurring in the majority of cases within the first month of treatment. Voltic-D<br />should be discontinued at the first appearance of skin rash, mucosal lesions or any other<br />signs of hypersensitivity.<br />SLE and mixed connective tissue disease:<br />In patients with systemic lupus erythematosus (SLE) and mixed connective tissue disorders<br />there may be an increased risk of aseptic meningitis (see section 4.8 Undesirable effects).<br />Cardiovascular and cerebrovascular effects:<br />Patients with significant risk factors for cardiovascular events (e.g. hypertension,<br />hyperlipidaemia, diabetes mellitus, smoking) should only be treated with Diclofenac after<br />careful consideration. As the cardiovascular risks of Diclofenac may increase with dose and<br />duration of exposure, the shortest duration possible and the lowest effective daily dose<br />should be used. The patient&#39;s need for symptomatic relief and response to therapy should be<br />re-evaluated periodically.<br />Appropriate monitoring and advice are required for patients with a history of hypertension<br />and/or mild to moderate congestive heart failure as fluid retention and oedema have been<br />reported in association with NSAID therapy including Diclofenac.<br />Clinical trial and epidemiological data consistently point towards increased risk of arterial<br />thrombotic events (for example myocardial infarction or stroke) associated with the use of<br />Diclofenac, particularly at high dose (150mg daily) and in long term treatment</p><p>Patients with uncontrolled hypertension, congestive heart failure, established ischaemic<br />heart disease, peripheral arterial disease, and/or cerebrovascular disease should only be<br />treated with Diclofenac after careful consideration.<br />Haematological effects:<br />Use of Voltic-D dispersible tablets is recommended only for short term treatment.<br />During prolonged treatment with Voltic-D, as with other NSAIDs, monitoring of the blood<br />count is recommended.<br />Diclofenac may reversibly inhibit platelet aggregation (see anticoagulants in section 4.5<br />Interaction with other medicaments and other forms of interactions). Patients with defects of<br />haemostasis, bleeding diathesis or haematological abnormalities should be carefully<br />monitored.<br />Pre-existing asthma:<br />In patients with asthma, seasonal allergic rhinitis, swelling of the nasal mucosa (i.e. nasal<br />polyps), chronic obstructive pulmonary diseases or chronic infections of the respiratory tract<br />(especially if linked to allergic rhinitis-like symptoms), reactions on NSAIDs like asthma<br />exacerbations (so called intolerance to analgesics / analgesics asthma), Quincke&#39;s oedema or<br />urticaria are more frequent than in other patients. Therefore, special precaution is<br />recommended in such patients (readiness for emergency). This is applicable as well for<br />patients who are allergic to other substances, e.g. with skin reactions, pruritus or urticaria.<br />Like other drugs that inhibit prostaglandin synthetase activity, Diclofenac sodium and other<br />NSAIDs can precipitate bronchospasm if administered to patients suffering from, or with a<br />previous history of bronchial asthma.<br />Female fertility:<br />The use of Diclofenac may impair female fertility and is not recommended in women<br />attempting to conceive. In women who may have difficulties conceiving or who are<br />undergoing investigation of infertility, withdrawal of Voltic-D should be considered (see<br />section 4.6 Pregnancy and lactation).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The following interactions include those observed with Diclofenac gastro-resistant tablets<br />and/or other pharmaceutical forms of Diclofenac.<br />Lithium: If used concomitantly, Diclofenac may increase plasma concentrations of<br />lithium<br />Monitoring of the serum lithium level is recommended.<br />Digoxin: If used concomitantly, Diclofenac may raise plasma concentrations of digoxin.<br />Monitoring of the serum digoxin level is recommended.<br />Diuretics and antihypertensive agents: Like other NSAIDs, concomitant use of<br />Diclofenac with diuretics and antihypertensive agents (e.g. beta-blockers, angiotensin<br />converting enzyme (ACE) inhibitors may cause a decrease in their antihypertensive effect<br />via inhibition of vasodilatory prostaglandin synthesis.<br />Therefore, the combination should be administered with caution and patients, especially the<br />elderly, should have their blood pressure periodically monitored. Patients should be<br />adequately hydrated and consideration should be given to monitoring of renal function after<br />initiation of concomitant therapy periodically thereafter, particularly for diuretics and ACE<br />inhibitors due to the increased risk of nephrotoxicity.<br />Drugs known to cause hyperkalemia: Concomitant treatment with potassium-sparing<br />diuretics, ciclosporin, tacrolimus or trimethoprim may be associated with increased serum<br />potassium levels, which should therefore be monitored frequently (see section 4.4 Special<br />warnings and precautions for use).<br />Anticoagulants and anti-platelet agents: Caution is recommended since concomitant<br />administration could increase the risk of bleeding (see section 4.4 Special warnings and<br />precautions for use). Although clinical investigations do not appear to indicate that<br />Diclofenac has an influence on the effect of anticoagulants, there are isolated reports of an<br />increased risk of haemorrhage in patients receiving Diclofenac and anticoagulant<br />concomitantly (see section 4.4 Special warnings and precautions for use). Therefore, to be<br />certain that no change in anticoagulant dosage is required, close monitoring of such patients<br />is required. As with other nonsteroidal anti-inflammatory agents, Diclofenac in a high dose<br />can reversibly inhibit platelet aggregation.<br />Other NSAIDs including cyclooxygenase-2 selective inhibitors and corticosteroids: Coadministration<br />of Diclofenac with other systemic NSAIDs or corticosteroids may increase<br />the risk of gastrointestinal bleeding or ulceration. Avoid concomitant use of two or more<br />NSAIDs (see section 4.4 Special warnings and precautions for use).</p><p>Selective serotonin reuptake inhibitors (SSRIs): Concomitant administration of SSRI&#39;s<br />may increase the risk of gastrointestinal bleeding (see section 4.4 Special warnings and<br />precautions for use).<br />Antidiabetics: Clinical studies have shown that Diclofenac can be given together with oral<br />antidiabetic agents without influencing their clinical effect. However there have been<br />isolated reports of hypoglycaemic and hyperglycaemic effects necessitating changes in the<br />dosage of the antidiabetic agents during treatment with Diclofenac. For this reason,<br />monitoring of the blood glucose level is recommended as a precautionary measure during<br />concomitant therapy.<br />Methotrexate: Diclofenac can inhibit the tubular renal clearance of methotrexate hereby<br />increasing methotrexate levels. Caution is recommended when NSAIDs, including<br />Diclofenac, are administered less than 24 hours before treatment with methotrexate, since<br />blood concentrations of methotrexate may rise and the toxicity of this substance be increase.<br />Cases of serious toxicity have been reported when methotrexate and NSAIDs including<br />Diclofenac are given within 24 hours of each other. This interaction is mediated through<br />accumulation of methotrexate resulting from impairment of renal excretion in the presence<br />of the NSAID.<br />Ciclosporin: Diclofenac, like other NSAIDs, may increase the nephrotoxicity of ciclosporin<br />due to the effect on renal prostaglandins. Therefore, it should be given at doses lower than<br />those that would be used in patients not receiving ciclosporin.<br />Tacrolimus: Possible increased risk of nephrotoxicity when NSAIDs are given with<br />tacrolimus. This might be mediated through renal antiprostagladin effects of both NSAID<br />and calcineurin inhibitor.<br />Quinolone antibacterials: Convulsions may occur due to an interaction between<br />quinolones and NSAIDs. This may occur in patients with or without a previous history of<br />epilepsy or convulsions. Therefore, caution should be exercised when considering the use of<br />a quinolone in patients who are already receiving an NSAID.<br />Phenytoin: When using phenytoin concomitantly with Diclofenac, monitoring of phenytoin<br />plasma concentrations is recommended due to an expected increase in exposure to<br />phenytoin.<br />Colestipol and cholestyramine: These agents can induce a delay or decrease in absorption<br />of Diclofenac. Therefore, it is recommended to administer Diclofenac at least one hour before<br />or 4 to 6 hours after administration of colestipol/ cholestyramine.</p><p>Cardiac glycosides: Concomitant use of cardiac glycosides and NSAIDs in patients may<br />exacerbate cardiac failure, reduce GFR and increase plasma glycoside levels.<br />Mifepristone: NSAIDs should not be used for 8-12 days after mifepristone administration<br />as NSAIDs can reduce the effect of mifepristone.<br />Potent CYP2C9 inhibitors: Caution is recommended when co-prescribing Diclofenac with<br />potent CYP2C9 inhibitors (such as voriconazole), which could result in a significant<br />increase in peak plasma concentrations and exposure to Diclofenac due to inhibition of<br />Diclofenac metabolism.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pregnancy<br />Pregnancy Category C in first &amp; second Trimester and Pregnancy Category D in third trimester<br />If &lt; 30 weeks Category C; if &gt; 30 weeks Category D.<br />Inhibition of prostaglandin synthesis may adversely affect the pregnancy and/or the<br />embryo/foetal development. Data from epidemiological studies suggest an increased risk of<br />miscarriage and or cardiac malformation and gastroschisis after use of a prostaglandin synthesis<br />inhibitor in early pregnancy. The absolute risk for cardiovascular malformation was increased<br />from less than 1% up to approximately 1.5%.<br />The risk is believed to increase with dose and duration of therapy. In animals, administration of<br />a prostaglandin synthesis inhibitor has shown to result in increased pre-and post-implantation<br />loss and embryo-foetal lethality.<br />In addition, increased incidences of various malformations, including cardiovascular, have been<br />reported in animals given a prostaglandin synthesis inhibitor during organogenetic period. If<br />Diclofenac is used by a woman attempting to conceive, or during the 1st trimester of pregnancy,<br />the dose should be kept as low and duration of treatment as short as possible.<br />During the third trimester of pregnancy, all prostaglandin synthesis inhibitors may expose the<br />foetus to:<br />- cardiopulmonary toxicity (with premature closure of the ductus arteriosus and pulmonary<br />hypertension)<br />- renal dysfunction, which may progress to renal failure with oligo-hydroamniosis<br />The mother and the neonate, at the end of the pregnancy, to:</p><p>- possible prolongation of bleeding time, an anti-aggregating effect which may occur even at<br />very low doses<br />- inhibition of uterine contractions resulting in delayed or prolonged labour<br />Consequently, Voltic-D is contraindicated during the third trimester of pregnancy.<br />Lactation<br />Like other NSAIDs, Diclofenac passes into breast milk in small amounts. Therefore, Diclofenac<br />should not be administered during breast feeding in order to avoid undesirable effects in the<br />infant (see section 5.2 Pharmacokinetic properties).<br />Female fertility<br />As with other NSAIDs, the use of Diclofenac may impair female fertility and is not<br />recommended in women attempting to conceive. In w ome n who may have difficulties<br />conceiving or who are undergoing investigation of infertility, withdrawal of Diclofenac should<br />be considered.<br />See also section 4.4 Special warnings and precautions for use, regarding female fertility.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Patients who experience visual disturbances, dizziness, somnolence, central nervous system<br />disturbances, drowsiness, or fatigue while taking NSAIDs should refrain from driving or<br />operating machinery.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Adverse reactions are ranked under the heading of frequency, the most frequent first, using the<br />following convention: very common: (&gt;1/10); common (&ge; 1/100, &lt;1/10); uncommon (&ge;<br />1/1,000, &lt;1/100); rare (&ge;1/10,000, &lt;1/1000); very rare (&lt;1/10,000); not known: cannot be<br />estimated from available data.<br />The following undesirable effects include those reported with other short-term or long-term<br />use.</p><p>Table 1<br />Blood and lymphatic system disorders<br />Very rare Thrombocytopenia, leucopoenia, anaemia (including haemolytic and<br />aplastic anaemia), agranulocytosis.<br />Immune system disorders<br />Rare Hypersensitivity, anaphylactic and anaphylactoid reactions (including<br />hypotension and shock).<br />Very rare Angioneurotic oedema (including face oedema).<br />Psychiatric disorders<br />Very rare Disorientation, depression, insomnia, nightmare, irritability, psychotic<br />disorder.<br />Nervous system disorders<br />Common Headache, dizziness.<br />Rare Somnolence, tiredness.<br />Very rare Paraesthesia, memory impairment, convulsion, anxiety, tremor, aseptic<br />meningitis, taste disturbances, cerebrovascular accident.<br />Unknown Confusion, hallucinations, disturbances of sensation, malaise.<br />Eye disorders<br />Very rare Visual disturbance, vision blurred diplopia.<br />Unknown Optic neuritis.<br />Ear and labyrinth disorders<br />Common Vertigo.<br />Very rare Tinnitus, hearing impaired.<br />Cardiac disorders<br />Very rare Palpitations, chest pain, cardiac failure, myocardial infarction.<br />Vascular disorders<br />Very rare Hypertension, hypotension, vasculitis.</p><p>Respiratory, thoracic and mediastinal disorders<br />Rare Asthma (including dyspnoea).<br />Very rare Pneumonitis.<br />Gastrointestinal disorders<br />Common Nausea, vomiting, diarrhoea, dyspepsia, abdominal pain, flatulence,<br />anorexia.<br />Rare Gastritis, gastrointestinal haemorrhage, haematemesis, diarrhoea haemorrhagic,<br />melaena, gastrointestinal ulcer with or without bleeding or perforation<br />(sometimes fatal particularly in the elderly).<br />Very rare Colitis (including haemorrhagic colitis and exacerbation of ulcerative colitis<br />or Crohn&#39;s disease), constipation, stomatitis (including ulcerative stomatitis),<br />glossitis, oesophageal disorder, diaphragm-like intestinal strictures, pancreatitis.<br />Hepatobiliary disorders<br />Common Transaminases increased.<br />Rare Hepatitis, jaundice, liver disorder.<br />Very rare Fulminant hepatitis, hepatic necrosis, hepatic failure.<br />Skin and subcutaneous tissue disorders<br />Common Rash.<br />Rare Urticaria.<br />Very rare Bullous eruptions, eczema, erythema, erythema multiforme, Stevens- Johnson<br />syndrome, toxic epidermal necrolysis (Lyell&#39;s syndrome), dermatitis exfoliative,<br />loss of hair, photosensitivity reaction, purpura, allergic purpura, pruritus.<br />Renal and urinary disorders<br />Very rare Acute renal failure, haematuria, proteinuria, nephrotic syndrome, interstitial<br />nephritis, renal papillary necrosis.<br />General disorders and administration site conditions<br />Rare Oedema</p><p>Reproductive system and breast disorders<br />Very rare Impotence<br />Clinical trial and epidemiological data consistently point towards an increased risk of arterial<br />thrombotic events (for example myocardial infarction or stroke) associated with the use of<br />Diclofenac, particularly at high doses (150mg daily) and in long term treatment (see sections 4.3<br />and 4.4 for Contraindications and Special warnings and special precautions for use).<br />To report any side effects please contact National Pharmacovigilance and Drug Safety Center<br />(NPC) details below:<br />The National Pharmacovigilance and Drug Safety Centre (NPC)<br />&bull; Fax: +966-11-205-7662<br />&bull; Call NPC at +966-11-2038222, Exts: 2317-2356-2353-2354-2334-2340.<br />&bull; Toll free phone: 8002490000<br />&bull; E-mail: npc.drug@sfda.gov.sa<br />&bull; Website: www.sfda.gov.sa/npc</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Symptoms<br />There is no typical clinical picture resulting from Diclofenac over dosage. Over dosage can<br />cause symptoms such as headache, nausea, vomiting, epigastric pain, gastrointestinal<br />bleeding, diarrhoea, dizziness, disorientation, excitation, coma, drowsiness, tinnitus, fainting<br />or convulsions. In the case of significant poisoning acute renal failure and liver damage are<br />possible.<br />Therapeutic measures<br />Management of acute poisoning with NSAIDs, including Diclofenac, essentially consists of<br />supportive measures and symptomatic treatment. Supportive measures and symptomatic<br />treatment should be given for complications such as hypotension, renal failure, convulsions,<br />gastrointestinal disorder, and respiratory depression.<br />Special measures such as forced diuresis, dialysis or haemo-perfusion are probably of no<br />help in eliminating NSAIDs, including Diclofenac, due to high protein binding and extensive<br />metabolism.</p><p>Activated charcoal may be considered after ingestion of a potentially toxic overdose, and<br />gastric decontamination (e.g. vomiting, gastric lavage) after ingestion of a potentially life<br />threatening overdose.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pharmacotherapeutic group<br />Nonsteroidal anti-inflammatory drugs (NSAIDs).<br />ATC Code: M01AB05<br />Mechanism of action<br />Diclofenac is a nonsteroidal agent with marked analgesic/anti- inflammatory properties. It is<br />an inhibitor of prostaglandin synthetase, (cyclo-oxygenase).<br />Diclofenac sodium in vitro does not suppress proteoglycan biosynthesis in cartilage at<br />concentrations equivalent to the concentrations reached in human beings.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Absorption<br />Absorption begins immediately upon administration. Mean peak plasma concentrations of<br />Diclofenac are reached at about 1 hour 0.9 &plusmn; 0.4&mu;g/ml (1&mu;g/mL &equiv; 3&mu;mol/L). Ingestion of<br />dispersible tablets together with or immediately after a meal does not delay the onset of<br />absorption but reduces the amount absorbed by on average of about 16% and the maximum<br />concentrations by about 50%.<br />Bioavailability:<br />The bioavailability is 82% of that of enteric-coated tablets. Ingestion with food affects the<br />bioavailability (see above).<br />Pharmacokinetic behaviour does not change on repeated administration. Accumulation does<br />not occur, provided the recommended dosage intervals are observed.</p><p>Distribution<br />The active substance is 99.7% protein bound, mainly to albumin (99.4%).<br />Diclofenac enters the synovial fluid, where maximum concentrations are measured 2-4<br />hours after the peak plasma values have been attained. The apparent half-life for elimination<br />from the synovial fluid is 3-6 hours. Two hours after reaching the peak plasma values,<br />concentrations of the active substance are already higher in the synovial fluid than they are<br />in the plasma and they remain higher for up to 12 hours.<br />Diclofenac was detected in a low concentration (100 ng/mL) in breast milk in one nursing<br />mother. The estimated amount ingested by an infant consuming breast milk is equivalent to<br />a 0.03 mg/kg/day dose (see section 4.6 Pregnancy and lactation).<br />Metabolism<br />Biotransformation of Diclofenac takes place partly by glucuronidation of the intact molecule,<br />but mainly by single and multiple hydroxylation and methoxylation, resulting in several<br />phenolic metabolites, most of which are converted to glucuronide conjugates. Two phenolic<br />metabolites are biologically active, but to a much lesser extent than Diclofenac.<br />Elimination<br />The total systemic clearance of Diclofenac in plasma is 263 &plusmn; 56 mL/min (mean value &plusmn;<br />SD). The terminal half-life in plasma is 1-2 hours. Four of the metabolites, including the two<br />active ones, also have short plasma half-lives of 1-3 hours.<br />About 60% of the administered dose is excreted in the urine in the form of the glucuronide<br />conjugate of the intact molecule and as metabolites, most of which are also converted to<br />glucuronide conjugates. Less than 1% is excreted as unchanged substance. The rest of the<br />dose is eliminated as metabolites through the bile in the faeces.<br />Characteristics in patients<br />Elderly: No relevant age-dependent differences in the drug&#39;s absorption, metabolism, or<br />excretion have been observed, other than the finding that in five elderly patients, a 15 minute<br />iv infusion resulted in 50% higher plasma concentrations than expected with young healthy<br />subjects.<br />Patients with renal impairment: In patients suffering from renal impairment, no<br />accumulation of the unchanged active substance can be inferred from the single-dose<br />kinetics when applying the usual dosage schedule. At a creatinine clearance of &lt;10 mL/min,</p><p>the calculated steady-state plasma levels of the hydroxy metabolites are about 4 times higher<br />than in normal subjects. However, the metabolites are ultimately cleared through the bile.<br />Patients with hepatic disease: In patients with chronic hepatitis or non-decompensated<br />cirrhosis, the kinetics and metabolism of Diclofenac are the same as in patients without liver<br />disease.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>None stated.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>􀁸 Microcrystalline Cellulose<br />􀁸 Crospovidone<br />􀁸 Povidone<br />􀁸 Sodium Lauryl Suphate<br />􀁸 Colloidal Silicon Dioxide</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>.None known.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                3 years.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Do not store above 30&deg;C.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Primary: Alu-PVC/Aclar Blister.<br /><br />Secondary: 2 Blisters of 10 tablets each packed in outer carton with PIL.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No special requirements.<br /><br />Any unused product or waste material should be disposed of in accordance with local<br />requirements.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Jamjoom Pharmaceuticals Company Limited.
P.O. Box 6267.
Jeddah- 21442.
Kingdom of Saudi Arabia.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                10/2018
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>